Disclosures for "New Organ Manifestations Associated with Neurosarcoidosis Years Later in a Longitudinal Patient-reported Cohort: Real-world Data from the Foundation for Sarcoidosis Research Patient Registry"
-
Ms. Hoover has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research.
-
Dr. Fechter-Leggett has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research.
-
Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
-
The institution of Dr. Harper has received research support from NIMHD. The institution of Dr. Harper has received research support from NCATS.
-
An immediate family member of Dr. Kurz has received personal compensation for serving as an employee of Grainger. Dr. Kurz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation for Sarcoidosis Research. An immediate family member of Dr. Kurz has or had stock in Grainger. The institution of Dr. Kurz has received research support from Biogen.
-
Ms. McGowan has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research. Ms. McGowan has a non-compensated relationship as a Consulting/Program Support with Keenova (formerly Mallinckrodt Pharmaceuticals) that is relevant to AAN interests or activities. Ms. McGowan has a non-compensated relationship as a Consulting/Program Support with Boehringer Ingelheim that is relevant to AAN interests or activities. Ms. McGowan has a non-compensated relationship as a Consulting/Clinical Trial Support with Avalyn that is relevant to AAN interests or activities. Ms. McGowan has a non-compensated relationship as a Consulting/Program Support with Insmed that is relevant to AAN interests or activities.
-
Ms. Sandison has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research .
-
Dr. Serchuck has a non-compensated relationship as a BOARD OF DIRECTORS with FOUNDATION FOR SARCOIDOSIS RESEARCH that is relevant to AAN interests or activities.
-
Mrs. Shivas has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research. Mrs. Shivas has a non-compensated relationship as a consulting/program support with Keenova that is relevant to AAN interests or activities. Mrs. Shivas has a non-compensated relationship as a consulting/program support with Boehringer Ingelheim that is relevant to AAN interests or activities. Mrs. Shivas has a non-compensated relationship as a Consulting with Avalyn that is relevant to AAN interests or activities. Mrs. Shivas has a non-compensated relationship as a Consulting with Insmed that is relevant to AAN interests or activities.